new data
Guard shares soar as new data show clinical benefit despite missing primary endpoint
Anika Sharma
Guard Therapeutics is staging a remarkable recovery following a setback in its phase 2 clinical trial for kidney injury treatment. ...
Guard Therapeutics is staging a remarkable recovery following a setback in its phase 2 clinical trial for kidney injury treatment. ...
pharmtales
Latest Pharma News & Insights